← back to search

Chelsea Carle

The University of Sydney · AU
Area of research
Infectious Diseases · Oncology
Research interest
Research interests include COVID-19 Clinical Research Studies, COVID-19 and healthcare impacts, Prostate Cancer Diagnosis and Treatment, and Smoking Behavior and Cessation.
h-index
6
citations
258
works
8
NIH funding
primary concept
email

Recent publications

Risk of <scp>COVID</scp>‐19 death for people with a pre‐existing cancer diagnosis prior to <scp>COVID</scp>‐19‐vaccination: A systematic review and meta‐analysis
International Journal of Cancer 2023cited by 12position: middledoi
Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis
EClinicalMedicine 2022cited by 198position: middledoi
Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence
Journal of Cancer Policy 2022cited by 16position: middledoi
The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence
Journal of Cancer Policy 2022cited by 6position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Isabelle Soerjomataram · World Health Organization3 papers (2022–2022)Freddie Bray · Centre National de la Recherche Scientifique3 papers (2022–2022)Suzanne Hughes · The University of Sydney3 papers (2022–2022)Julia Steinberg · The University of Sydney3 papers (2022–2022)Sam Egger · University of Sydney3 papers (2022–2022)Michael Caruana · University of Sydney3 papers (2022–2022)Ophira Ginsburg · The George Institute for Global Health3 papers (2022–2022)Dianne L. O’Connell · The University of Sydney3 papers (2022–2022)Karen Canfell · Sydney Local Health District3 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2022–2022)Timothy P. Hanna · Columbia University2 papers (2022–2022)Harriet Hui · The University of Sydney2 papers (2022–2022) · 2 papers (2022–2022)Sarsha Yap · The University of Sydney2 papers (2022–2022)Denise Campbell · University of Michigan–Flint2 papers (2022–2022)Ajay Aggarwal · Guy's and St Thomas' NHS Foundation Trust2 papers (2022–2022)Erica Liebermann · New York University1 papers (2022–2022)Peter Sarich · The University of Sydney1 papers (2022–2022)Citadel J. Cabasag · IQVIA (France)1 papers (2022–2022)